Isolated hepatic perfusion in the pig with TNF-alpha with and without melphalan
1997

Isolated Hepatic Perfusion with TNF-alpha and Melphalan in Pigs

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): IHM Borel Rinkes, MR de Vries, AM Jonker, TJG Swaak, CE Hack, PTGA Nooyen, T Wiggers, AMM Eggermont

Primary Institution: Rotterdam Cancer Institute/University Hospital Rotterdam

Hypothesis

Isolated hepatic perfusion with TNF-alpha and melphalan is feasible and safe for treating irresectable hepatic malignancies.

Conclusion

The study found that isolated hepatic perfusion with TNF-alpha and melphalan is technically feasible and results in minimal systemic drug exposure and mild, transient hepatotoxicity.

Supporting Evidence

  • Stable perfusion was achieved in all animals with minimal systemic leakage of TNF-alpha.
  • All but one pig tolerated the procedure well, and no significant systemic toxicity was observed.
  • Mild transient hepatotoxicity was seen to a similar extent in all animals, including controls.

Takeaway

Doctors tested a new way to treat liver cancer in pigs using special drugs, and it worked well without causing too many side effects.

Methodology

Ten healthy pigs underwent isolated hepatic perfusion with TNF-alpha and melphalan, with various measurements taken to assess toxicity and drug levels.

Limitations

The study was conducted in pigs, and results may not directly translate to humans.

Participant Demographics

Ten healthy pigs weighing 25-33 kg.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication